Christiane Volbracht is a Principal Scientist in Neuroscience at H. Lundbeck A/S in Denmark, with over 20 years of experience in drug discovery within the pharmaceutical industry. She has served as project lead on both industry-funded and European Union-funded preclinical research projects. Prior to her current role, she was a Postdoctoral Research Fellow at the Institute of Molecular and Cell Biology in Singapore, following the completion of her PhD at the University of Konstanz in Germany. Her primary research focus is on target identification for drug development in age-related neurodegenerative diseases, including Alzheimer's disease.